The Valley Desk

NCT02383927 · Interventional trial

Phase II Study of Tipifarnib in Squamous Head and Neck Cancer With HRAS Mutations

Overall registry status Completed

Phase 2

Conditions HRAS Mutant Tumor, Other Squamous Cell Carcinoma (SCC) With HRAS Mutant Tumor, Squamous Cell Carcinoma Head and Neck Cancer (HNSCC), Thyroid Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov